The Oxford Cancer network has launched at the University of Oxford to represent and coordinate cancer research in Oxford. The pan-divisional initiative aims to bring together the collective force of cancer research, and outreach and care, taking place across the city.
The network is a collaborative effort with Oxford University Hospitals NHS FT (OUH), which involves a wide range of staff with expertise in immunology, data science, cell biology, physical science, and drug development. Oxford Cancer intends to bring the expertise together, as a way to facilitate multi-disciplinary research across its partners.
Some of the main aims hope to tackle key challenges in cancer care, through the development and delivery of novel strategies for early detection and curative treatment, of a range of different types of cancer.
Professor Mark Middleton, the NIHR Oxford BRC Co-theme Lead for Cancer, and Co-Director of Oxford Cancer, said: "We are very excited to launch the new Oxford Cancer network, with the aim of bringing together all those with a shared interest in cancer, to address urgent and emerging cancer patient needs, informed by the best basic science."
The latest fundamental scientific discoveries, world data science, and unique Oxford technological developments, will be used to inform the research. The University of Oxford and OUH staff will be facilitated by the new network, helping break down barriers between research facilities, and the expertise that help researchers achieve greater awareness surrounding their discoveries.
The resources at the cancer centre are also available to all Oxford researchers who feel their work is relevant to cancer research. There are currently more than 900 cancer-related researchers across five OUH and University divisions. This means that the staff are well placed to solve key cancer research challenges through their innovative research discoveries.
